StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 9.5
Power Rank trend -> Rising
07/26/2024 16:00:00 EST
Organon & Co (OGN)
Industry: Drug Manufacturers - General
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, OGN has been trading in a range between $21.54 and $19.92 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
OGN is breaking above top of the recent 20 day range at $21.96 and appears that it could have some more upside. If it enters a yellow zone the trend may be faltering - consider exiting or taking profits. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
Organon & Co $OGN entered a Green zone 12 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $29.29, a potential upside of 32% from the recent price of 22.19. The stock is trading 1.58% (potential upside) below its 52 week high of $22.54 and 110.73 % (potential downside) above its 52 week low of $10.53 - based on the recent price.
Company Summary
Organon & Co develops and delivers health solutions through a portfolio of prescription therapies and medical devices within women's health in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon, a long-acting reversible contraceptive; NuvaRing, a monthly vaginal contraceptive ring; Cerazette, a daily pill used to prevent pregnancy; Marvelon, progestin and estrogen used as daily pills to prevent pregnancy; Follistim AQ, used to promote the development of multiple ovarian follicles in assisted reproduction technology procedures; Elonva, an ovarian follicle stimulant; Ganirelix Acetate Injection, an injectable antagonist; and Jada, for abnormal postpartum uterine bleeding or hemorrhage.
News
| 3 Medical Services Industry Stocks to Buy as Healthcare Wage Increases The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ICLR, OGN and DOCS are set to gain the most. Source: Zacks Investment Research Fri, 26 Jul 2024 11:11:43 -0400 Sentiment: Positive |
| Organon (OGN) Upgraded to Strong Buy: What Does It Mean for the Stock? Organon (OGN) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. Source: Zacks Investment Research Wed, 24 Jul 2024 13:00:51 -0400 Sentiment: Positive |
| Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store. Source: Zacks Investment Research Tue, 23 Jul 2024 10:00:48 -0400 Sentiment: Positive |
| 20 value stocks with high dividend yields and expected room to raise payouts Last week's action in the stock market might have signaled a long-awaited shift away from a focus on Big Tech in the stock market to overlooked pockets of value. Source: Market Watch Sat, 20 Jul 2024 08:00:00 -0400 Sentiment: Positive |
| Organon (OGN) Increases Yet Falls Behind Market: What Investors Need to Know In the closing of the recent trading day, Organon (OGN) stood at $20.81, denoting a +0.39% change from the preceding trading day. Source: Zacks Investment Research Tue, 16 Jul 2024 19:00:59 -0400 Sentiment: Neutral |
Technicals 52 Week Hi: 22.5397 52 Week Low: 10.5257 Beta: 0.811 50 Day MA: 20.9122 200 Day MA: 17.2403 Earnings / Revenue Trends Qtr Earnings Growth YOY: 0.13 Qtr Revenue Growth YOY: 0.055 Forward PE: 5.0302 Trailing PE: 5.3873